Argenx
ARGX
#627
Rank
NZ$52.42 B
Marketcap
$864.82
Share price
1.13%
Change (1 day)
-2.04%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

P/S ratio for Argenx (ARGX)

P/S ratio as of September 2024 (TTM): 19.9

According to Argenx 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 19.8539. At the end of 2024 the company had a P/S ratio of 16.0.

P/S ratio history for Argenx from 2022 to 2021

PS ratio at the end of each year

Year P/S ratio Change
202416.0-13.14%
202318.4-63.94%
202251.0-17.67%
202162.0
201978.5-34.81%
2018120201.34%
201739.9
201425.2